Coherus Oncology, Inc.CHRSNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank46
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Percentile
P46
Within normal range
vs 5Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$-170.29M-697.4%
2024$28.51M+112.0%
2023$-237.89M+18.5%
2022$-291.75M-1.6%
2021$-287.10M-317.1%
2020$132.24M+47.2%
2019$89.83M+142.9%
2018$-209.34M+12.1%
2017$-238.17M-87.0%
2016$-127.34M-